HTG - EdgeSeq DLBCL Cell of Origin Assay EU
The HTG EdgeSeq DLBCL Cell of Origin Assay EU is an in vitro diagnostic assay that uses gene expression profiling (GEP) to determine the cell of origin (COO) subtype of diffuse large B-cell lymphoma (DLBCL) tumors from formalin-fixed, paraffin-embedded (FFPE) tissue section. The gene expression data are assessed by a classification algorithm and the tumor samples determined to be of the activated B-cell like (ABC), germinal B-cell like (GCB), or unclassified subtype. The assay is performed using the HTG EdgeSeq system with sequencing performed on an Illumina MiSeq sequencer. Cell of origin results are reported by the HTG Edge host system.
-
Most popular related searches
Features and Benefits
Determine DLBCL cell of origin classification with as little as 1.5 mm2 of DLBCL tumor tissue - the amount typically seen from a single section of a needle core biopsy.
Customer reviews
No reviews were found for HTG - EdgeSeq DLBCL Cell of Origin Assay EU. Be the first to review!